Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1947-1955

  Bao, Lihua ^a   Osawe, Iyabo ^a   Haas, Mark ^b   Quigg, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C3A RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 1BETA; PHOSPHATASE; PROTEIN KINASE B; RANTES; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHROMOSOME 10; CONTROLLED STUDY; INFLAMMATORY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

EID: 22544469404     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1947     Document Type: Article

References (73)

1. Dalmasso, A. P. 1986. Complement in the pathophysiology and diagnosis of human diseases. Crit. Rev. Clin. Lab. Sci. 24: 123-183.
2. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90: 1756-1760.
3. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
4. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
5. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
6. Kelley, V. E., S. Sneve, and S. Musinski. 1986. Increased renal thromboxane production in murine lupus nephritis. J. Clin. Invest. 77: 252-259.
7. Nicholson-Weller, A., and J. A. Halperin. 1993. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol. Res. 12: 244-257.
8. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
9. Martin, U., D. Bock, L. Arseniev, M. A. Tornetta, R. S. Ames, W. Bautsch, J. Kohl, A. Ganser, and A. Klos. 1997. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J. Exp. Med. 186: 199-207.
10. Peake, P. W., S. O'Grady, B. A. Pussell, and J. A. Charlesworth. 1999. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int. 56: 1729-1736.
11. Kèohl, J. 2001. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol. Immunol. 38: 175-187.
12. Bao, L., M. Haas, S. A. Boackle, D. M. Kraus, P. N. Cunningham, P. Park, J. J. Alexander, R. K. Anderson, K. Culhane, V. M. Holers, and R. J. Quigg, 2002. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J. Immunol. 168: 3601-3607.
13. Bao, L., M. Haas, D. M. Kraus, B. K. Hack, J. K. Rakstang, V. M. Holers, and R. J. Quigg. 2003. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J. Am. Soc. Nephrol. 14: 670.
14. Bao, L., J. Zhou, V. M. Holers, and R. J. Quigg. 2003. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J. Am. Soc. Nephrol. 14: 2516-2525.
15. Ames, R. S., D. Lee, J. J, Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al. 2001. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J. Immunol. 166: 6341-6348.
16. Quigg, R. J., A. Lim, M. Haas, J. J. Alexander, C. He, and M. C. Carroll. 1998. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 53: 320-330.
17. de Vries, B., J. Kohl, W. K. Leclercq, T. G. Wolfs, A. A. van Bijnen, P. Heeringa, and W. A. Buurman. 2003. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170: 3883-3889.
18. Hawlisch, H., M. Wills-Karp, C. L. Karp, and J. Kohl. 2004. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41: 123-131.
19. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
20. Hebert, L. A. 1991. The clearance of immune complexes from the circulation of man and other primates. Am. J. Kidney Dis. 17: 352-361.
21. Schifferli, J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35: 993-1003.
22. Yamamoto, K., and D. J. Loskutoff. 2000. Expression of transforming growth factor β and tumor necrosis factor α in the plasma and tissues of mice with lupus nephritis. Lab. Invest. 80: 1561-1570.
23. Lawson, B. R., G. J. Prud'homme, Y. Chang, H. A. Gardner, J. Kuan, D. H. Kono, and A. N. Theofilopoulos. 2000. Treatment of murine lupus with cDNA encoding IFN-γR/Fc. J. Clin. Invest. 106: 207-215.
24. Esfandiari, E., I. B. McInnes, G. Lindop, F. P. Huang, M. Field, M. Komai-Koma, X. Wei, and F. Y. Liew. 2001. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J. Immunol. 167: 5338-5347.
25. Huggins, M. L., F. P. Huang, D. Xu, G. Lindop, and D. I. Stott. 1999. Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-β1 gene therapy using attenuated Salmonella typhimurium as gene carrier. Lupus 8: 29-38.
26. Wuthrich, R. P., A. M. Jevnikar, F. Takei, L. H. Glimcher, and V. E. Kelley. 1990. Intercellular adhesion molecule-1 (ICAM-1) expression is up-regulated in autoimmune murine lupus nephritis. Am. J. Pathol. 136: 441-450.
27. Monsinjon, T., P. Gasque, P. Chan, A. Ischenko, J. J. Brady, and M. C. Fontaine. 2003. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J. 17: 1003-1014.
28. Khwaja, A., P. Rodriguez-Viciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16: 2783-2793.
29. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI3K and PKB. Nature 385: 544-548.
30. Takabayashi, T., S. Shimizu, B. D. Clark, M. Beinborn, J. F. Burke, and J. A. Gelfand. 2004. Interleukin-1 up-regulates anaphylatoxin receptors on mononuclear cells. Surgery 135: 544-554.
31. Laudes, I. J., J. C. Chu, M. Huber-Lang, R. F. Guo, N. C. Riedemann, J. V. Sarma, F. Mahdi, H. S. Murphy, C. Speyer, K. T. Lu, et al. 2002. Expression and function of C5a receptor in mouse microvascular endothelial cells. J. Immunol. 169: 5962-5970.
32. Gutzmer, R., M. Lisewski, J. Zwirner, S. Mommert, C. Diesel, M. Wittmann, A. Kapp, and T. Werfel. 2004. Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 111: 435-443.
33. Theofilopoulos, A. N., and B. R. Lawson. 1999. Tumour necrosis factor and other cytokines in murine lupus. Ann. Rheum Dis. 58(Suppl. 1): 149-155.
34. Boswell, J., M. Yui, D. Burt, and V. Kelley. 1988. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141: 3050-3054.
35. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-1 and interferon γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32: 495-503.
36. Gerard, C. 2003. Complement C5a in the sepsis syndrome: too much of a good thing? N. Engl. J. Med. 348: 167-169.
37. Rubin-Kelley, V. E., and A. M. Jevnikar. 1991. Antigen presentation by renal tubular epithelial cells. J. Am. Soc. Nephrol 2: 13-26.
38. Mendrick, D. L., D. M. Kelly, and H. G. Rennke. 1991. Antigen processing and presentation by glomerular visceral epithelium in vitro. Kidney Int. 39: 71-78.
39. 1 mice. Lancet 1: 1280-1284.
40. Sekine, H., C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson. 2001. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166: 6444-6451.
41. Watanabe, H., G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794.
42. Elliott, M. K., T. Jarmi, P. Ruiz, Y. Xu, V. M. Holers, and G. S. Gilkeson. 2004. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 65: 129-138.
43. Kildsgaard, J., T. J. Hollmann, K. W. Matthews, K. Bian, F. Murad, and R. A. Wetsel. 2000. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol 165: 5406-5409.
44. Werfel, T., K. Kirchhoff, M. Wittmann, G. Begemann, A. Kapp, F. Heidenreich, O. Gotze, and J. Zwirner. 2000. Activated human T lymphocytes express a functional C3a receptor. J. Immunol. 165: 6599-6605.
45. Boswell, J. M., M. A. Yui, S. Endres, D. W. Burt, and V. E. Kelley. 1988. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J. Immunol. 141: 118-124.
46. McHale, J. F., O. A. Harari, D. Marshall, and D. O. Haskard. 1999. TNF-α and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J. Immunol. 163: 3993-4000.
47. Rathanaswami, P., M. Hachicha, M. Sadick, T. J. Schall, and S. R. McColl. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 268: 5834-5839.
48. Verani, A., G. Scarlatti, M. Comar, E. Tresoldi, S. Polo, M. Giacca, P. Lusso, A. G. Siccardi, and D. Vercelli. 1997. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185; 805-816.
49. Heeger, P., G. Wolf, C. Meyers, M. J. Sun, S. C. O'Farrell, A. M. Krensky, and E. G. Neilson. 1992. Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int. 41: 220-225.
50. Wolf, G., S. Aberle, F. Thaiss, P. J. Nelson, A. M. Krensky, E. G. Neilson, and R. A. Stahl. 1993. TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 44: 795-804.
51. lpr mice. Kidney Int. 53: 1631-1641.
52. Kaplan, M. J. 2004. Apoptosis in systemic lupus erythematosus. Clin. Immunol. 112: 210-218.
53. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
54. Riedemann, N. C., R. F. Guo, I. J. Laudes, K. Keller, V. J. Sarma, V. Padgaonkar, F. S. Zetoune, and P. A. Ward. 2002. C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16: 887-888.
55. Nauta, A. J., M. R. Daha, O. Tijsma, B. van de Water, F. Tedesco, and A. Roos. 2002. The membrane attack complex of complement induces caspase activation and apoptosis. Eur. J. Immunol. 32: 783-792.
56. Hughes, J., M. Nangaku, C. E. Alpers, S. J. Shankland, W. G. Couser, and R. J. Johnson. 2000. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am. J. Physiol. 278: F747-F757.
57. Cole, D. S., and B. P. Morgan. 2003. Beyond lysis: how complement influences cell fate. Clin. Sci. (Lond.) 104: 455-466.
58. Serrao, K. L., J. D. Fortenberry, M. L. Owens, F. L. Harris, and L. A. Brown. 2001. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. 280: L298-L305.
59. De Vries, B., R. A. Matthijsen, T. G. Wolfs, A. A. Van Bijnen, P. Heeringa, and W. A. Buurman. 2003. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 75: 375-382.
60. Rana, A., P. Sathyanarayana, and W. Lieberthal. 2001. Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis 6: 83-102.
61. Daemen, M. A., C. van 't Veer, G. Denecker, V. H. Heemskerk, T. G. Wolfs, M. Clauss, P. Vandenabeele, and W. A. Buurman. 1999. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104: 541-549.
62. Cunningham, P. N., H. M. Dyanov, P. Park, J. Wang, K. A. Newell, and R. J. Quigg. 2002. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J. Immunol. 168: 5817-5823.
63. Schelling, J. R., and R. P. Cleveland. 1999. Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int. 56: 1313-1316.
64. Mitchell, D. A., M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport. 2002. Clq deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168: 2538-2543.
65. 1 mice with monoclonal antibody against Fas ligand. J. Autoimmun. 14: 151-157.
66. Seery, J. P., V. Cattell, and F. M. Watt. 2001. Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl- (β-o-methyl)-fluoromethylketone. J. Immunol. 167: 2452-2425.
67. Schaub, F. J., D. K. Han, W. C. Liles, L. D. Adams, S. A. Coats, R. K. Ramachandran, R. A. Seifert, S. M. Schwartz, and D. F. Bowen-Pope. 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6: 790-796.
68. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
69. Lenda, D. M., E. Kikawada, E. R. Stanley, and V. R. Kelley. 2003. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J. Immunol. 170: 3254-3262.
70. Scheid, M. P., and J. R. Woodgett. 2003. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546: 108-112.
71. Cantley, L. C., and B. G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96: 4240-4245.
72. Sulis, M. L., and R. Parsons. 2003. PTEN: from pathology to biology. Trends Cell Biol. 13: 478-483.
73. Deane, J. A., and D. A. Fruman. 2004. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22: 563-598.